Assessment of the clinical feasibility of detecting subtle blood-brain barrier leakage in cerebral small vessel disease using dynamic susceptibility contrast MRI
- PMID: 37137345
- DOI: 10.1016/j.mri.2023.04.004
Assessment of the clinical feasibility of detecting subtle blood-brain barrier leakage in cerebral small vessel disease using dynamic susceptibility contrast MRI
Abstract
Purpose: Cerebral small vessel disease (cSVD) involves several pathologies affecting the small vessels, including blood-brain barrier (BBB) impairment. Dynamic susceptibility contrast (DSC) MRI is sensitive to both blood perfusion and BBB leakage, and correction methods may be crucial for obtaining reliable perfusion measures. These methods might also be applicable to detect BBB leakage itself. This study investigated to what extent DSC-MRI can measure subtle BBB leakage in a clinical feasibility setting.
Methods: In vivo DCE and DSC data were collected from fifteen cSVD patients (71 (±10) years, 6F/9M) and twelve elderly controls (71 (±10) years, 4F/8M). DSC-derived leakage fractions were obtained using the Boxerman-Schmainda-Weisskoff method (K2). K2 was compared with the DCE-derived leakage rate Ki, obtained from Patlak analysis. Subsequently, differences were assessed between white matter hyperintensities (WMH), cortical gray matter (CGM), and normal-appearing white matter (NAWM). Additionally, computer simulations were performed to assess the sensitivity of DSC-MRI to BBB leakage.
Results: K2 showed significant differences between tissue regions (P < 0.001 for CGM-NAWM and CGM-WMH, and P = 0.001 for NAWM-WMH). Conversely, according to the computer simulations the DSC sensitivity was insufficient to measure subtle BBB leakage, as the K2 values were below the derived limit of quantification (4∙10-3 min-1). As expected, Ki was elevated in the WMH compared to CGM and NAWM (P < 0.001).
Conclusions: Although clinical DSC-MRI seems capable to detect subtle BBB leakage differences between WMH and normal-appearing brain tissue it is not recommended. K2 as a direct measure for subtle BBB leakage remains ambiguous as its signal effects are due to mixed T1- and T2∗-weighting. Further research is warranted to better disentangle perfusion from leakage effects.
Keywords: Blood-brain barrier leakage; Cerebral small vessel disease; DCE-MRI; DSC-MRI; Perfusion.
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease.Neurology. 2017 Jan 31;88(5):426-432. doi: 10.1212/WNL.0000000000003556. Epub 2016 Dec 28. Neurology. 2017. PMID: 28031395
-
Blood-brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging.Brain Imaging Behav. 2019 Apr;13(2):389-395. doi: 10.1007/s11682-018-9855-7. Brain Imaging Behav. 2019. PMID: 29572621 Free PMC article.
-
Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease.Neurology. 2019 Apr 9;92(15):e1669-e1677. doi: 10.1212/WNL.0000000000007263. Epub 2019 Mar 13. Neurology. 2019. PMID: 30867275
-
Magnetic Resonance Imaging of Blood-Brain Barrier permeability in Dementia.Neuroscience. 2021 Oct 15;474:14-29. doi: 10.1016/j.neuroscience.2021.08.003. Epub 2021 Aug 13. Neuroscience. 2021. PMID: 34400249 Free PMC article. Review.
-
Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations.Alzheimers Dement. 2019 Jun;15(6):840-858. doi: 10.1016/j.jalz.2019.01.013. Epub 2019 Apr 25. Alzheimers Dement. 2019. PMID: 31031101 Free PMC article. Review.
Cited by
-
Brain perfusion and blood-brain barrier permeability in systemic lupus erythematosus patients: Associations with disease activity, cognitive dysfunction, fatigue and pain.Neuroimage Rep. 2024 Dec 31;5(1):100232. doi: 10.1016/j.ynirp.2024.100232. eCollection 2025 Mar. Neuroimage Rep. 2024. PMID: 40567893 Free PMC article.
-
Imaging markers of neuroinflammation in aging and Alzheimer's disease and related dementia: A comprehensive review.Neurosci Biobehav Rev. 2025 Sep;176:106270. doi: 10.1016/j.neubiorev.2025.106270. Epub 2025 Jun 25. Neurosci Biobehav Rev. 2025. PMID: 40578495 Review.
-
Differentiation between glioblastoma and solitary brain metastases using perfusion and amide proton transfer weighted MRI.Front Neurosci. 2025 Feb 5;19:1533799. doi: 10.3389/fnins.2025.1533799. eCollection 2025. Front Neurosci. 2025. PMID: 39975970 Free PMC article.
-
Cerebral Microvascular Perfusion Assessed in Elderly Adults by Spin-Echo Dynamic Susceptibility Contrast MRI at 7 Tesla.Tomography. 2024 Jan 18;10(1):181-192. doi: 10.3390/tomography10010014. Tomography. 2024. PMID: 38250960 Free PMC article.
-
Noninvasive blood-brain barrier integrity mapping in patients with high-grade glioma and metastasis by multi-echo time-encoded arterial spin labeling.Magn Reson Med. 2025 May;93(5):2086-2098. doi: 10.1002/mrm.30415. Epub 2025 Jan 8. Magn Reson Med. 2025. PMID: 39777739 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous